Rentschler Biopharma USA News and Activities

Rentschler Biopharma USA is owned by Rentschler Biopharma. Rentschler Biopharma has a direct presence in 2 countries.

View the org chart displaying its 10 main executives

Most searched biographies at Rentschler Biopharma USA

• Tom Roberts, President, General Manager
• Deborah Bond, Senior Manager, Sales and Operations Planning
• Lauren Lamb, Director of Learning and Development

Popular executive movements at Rentschler Biopharma

• Torsten Woehr will join the company as Chief Executive Officer on Aug. 1, 2026  (posted on July 3 2026).
• Uwe Bücheler who is Interim Chief Executive Officer, will become Vice Chairman of the Board on Aug. 1, 2026  (posted on July 3 2026).
• Veit Bergendahl will join the company as Chief Operating Officer on Apr. 1, 2026  (posted on February 17 2026).

Click here to view some more movements at Rentschler Biopharma

Create your alert
to follow the executive moves at Rentschler Biopharma USA.

Rentschler Biopharma has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Rentschler Biopharma USA

• Whitepaper: Improving AAV vector quality with in-process monitoring of capsid formation
• Rentschler Biopharma kündigt größte Einzelinvestition in Deutschland an
• Rentschler Biopharma in Laupheim erhält ISO 27001-Zertifizierung für Informationssicherheitsmanagement
• Rentschler Biopharma stellt neue Toolbox zur Herstellung lentiviraler Vektoren für neuartige Therapien vor
• Interview: Building on a Pioneering Biomanufacturing Legacy with Client Centricity
• Rentschler Biopharmas hochmoderne Produktionslinie in Massachusetts vollständig in Betrieb
• Rentschler Biopharma ernennt Patrick Meyer zum Global Head BD Sales and Alliance Management
• Rentschler Biopharma ernennt Patrick Cushing zum VP Operations am US-Standort im Raum Boston
• Press Releases
• Rentschler Biopharma erhält die Goldmedaille bei den 20. jährlichen Team Massachusetts Economic Impact Awards
• View more press releases Close

Social media about Rentschler Biopharma USA

• Rentschler Biopharma USA on Wikipedia, Google News & Yahoo Finance
• Rentschler Biopharma USA on LinkedIn, X (Twitter) & YouTube